Products Categories
CAS No.: | 92118-27-9 |
---|---|
Name: | Fotemustine |
Molecular Structure: | |
Formula: | C9H19 Cl N3 O5 P |
Molecular Weight: | 315.694 |
Synonyms: | Phosphonicacid, [1-[[[(2-chloroethyl)nitrosoamino]carbonyl]amino]ethyl]-, diethyl ester(9CI); Fotemustine; Muphoran; Mustophorane; S 10036 |
Density: | 1.37 g/cm3 |
Melting Point: | 85° |
Boiling Point: | °Cat760mmHg |
Flash Point: | °C |
Hazard Symbols: | Xn |
Risk Codes: | 40 |
Safety: | 36/37 |
PSA: | 107.11000 |
LogP: | 2.92120 |
Molecular Structure of Fotemustine (CAS NO.92118-27-9):
IUPAC Name: 1-(2-Chloroethyl)-3-(1-diethoxyphosphorylethyl)-1-nitrosourea
Molecular Formula: C9H19ClN3O5P
Molecular Weight: 315.69
CAS Registry Number: 92118-27-9
Index of Refraction: 1.524
Molar Refractivity: 70.32 cm3
Molar Volume: 229.7 cm3
Surface Tension: 49.4 dyne/cm
Density: 1.37 g/cm3
Classification Code: Antineoplastic agents; Drug / Therapeutic Agent; Mutation data
Canonical SMILES: CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC
InChI: InChI=1S/C9H19ClN3O5P/c1-4-17-19(16,18-5-2)8(3)11-9(14)13(12-15)7-6-10/h8H,4-7H2,1-3H3,(H,11,14)
InChIKey: YAKWPXVTIGTRJH-UHFFFAOYSA-N
Fotemustine (CAS NO.92118-27-9) is used in the treatment of metastasising melanoma. A study has shown that Fotemustine produces over dacarbazine which improved response rates and increased survival in the treatment of disseminated cutaneous melanoma.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 60mg/kg (60mg/kg) | Cancer Research. Vol. 47, Pg. 6782, 1987. |
Fotemustine (CAS NO.92118-27-9), its Synonyms are (+-)-Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate ; Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate ; Fotemustina ; Fotemustinum ; Phosphonic acid, (1-((((2-chloroethyl)nitrosoamino)carbonyl)amino)ethyl)-, diethyl ester . Fotemustine is a nitrosourea alkylating agent.